CClinicalTrials.gg
Status unknownNCT04072172Updated Sep 11, 2019

Microcautery for the Treatment of Spider Leg Veins

An interventional study of Mole Freckle Pen in Microcautery for Leg Veins, sponsored by Assiut University. Status unknown. Open to female participants aged 20 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-11.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
20 Years to 45 Years
Sex
Female
01

Study summary

To Evaluate the role of micro-cauterization use in the treatment and disappearance of spider leg veins.

Read the detailed description

Spider veins on the lower limbs are very common and have been reported to be presented in 41% of women over 50 years old. Sclerotherapy as a traditional treatment for spider veins has a low cost, though it may have adverse sequelae. Lasers have shown fewer but still substantial complications as well.1 Spider veins are small superficial veins that widen and become visible, often on the legs and most cutaneous spider veins are abnormalities of the horizontal vascular skin plexus or capillary loops.2 Spider leg veins are composed of a feeder vessel and ectatic venous sprouts in the reticular dermis. Their depth is between 180 µm and 1 mm in the skin.3 Spider veins may have a diameter that reaches several millimetres and can be blue, purple or red and may appear in the form of thin lines, webs or branches.4 There is a scarce available data from literature about the role of micro-cauterization in the treatment of spider veins. The micro-cauterization is an alternative in management of spider veins that delivered via Mole Freckle Pen German Technology.4 Cautery is a safe and effective tool for the treatment of superficial and small skin lesions. It is simple, cheap, and requires minimal training and the results are usually satisfactory Technology Specifications with insulated micro steel needle use current: 5V / 1A of 5-speed free adjustment.5 The current study aims to evaluate the role for micro-cauterization in the treatment and disappearance of spider leg veins.

02

Conditions studied

  • Microcautery for Leg Veins
03

In context

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • were patients with spider veins of less than 2.0 mm in diameter.

Exclusion criteria

Exclusion Criteria:

  • were patients with diabetes, anticoagulation therapy and/or patients with a known history of keloids
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Female with leg spider veins

    Females at the age of 20 to 45 not known diabetics or hypertensive complaining of leg spider veins.

    Device: Mole Freckle Pen

Interventions

  • DeviceMole Freckle Pen

    Insulated micro steel needle use current: 5V / 1A of 5-speed free adjustment.5

06

What researchers measure

Primary outcomes

  1. Short term results after 3 weeks.

    Compare between the shape of spider leg veins pre and post the cauterization session depending on standard Oriented photos taken pre and post.

    Time frame: 3 weeks

Secondary outcomes

  1. Long term results after 3 months.

    Study, monitor and evaluate the long term results of the cautery session after 3 months and if there is any reappearance of the spider veins with a standard Oriented photos taken.

    Time frame: 3 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 11, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04072172
Lead sponsor
Assiut University
Responsible party
Doaa M. Selim (Principal Investigator, Assiut University) — Principal investigator
First posted
Aug 28, 2019
Start date
Sep 1, 2019 (estimated)
Primary completion
Sep 2020 (estimated)
Completion
Oct 2020 (estimated)
Last update
Sep 11, 2019

Study contacts

Doaa M. Selim, Resident
Contact
Doaamselim@gmail.com
00201009882011
Mohie Selim
Contact
Mohieselim2@yahoo.com
00966554716616
Doaa M. Selim, Resident
principal investigator · Assiut University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion